What we already know about the Post-COVID-19 Syndrome: A narrative review
DOI:
https://doi.org/10.33448/rsd-v11i12.34143Keywords:
COVID-19; SARS-CoV-2; Cough; Fatigue; Chronic disease.Abstract
As an increasingly number of patients recover from the acute COVID-19 disease, it has been observed that many face long lasting symptoms, referred as the Post-COVID-19 Syndrome. This article covers the most common signs and symptoms of this syndrome, its general aspects, and important complementary exams related to the disease. The manuscript is a narrative review, gathering new evidence published about the topic. The most common symptoms of the Post-COVID-19 Syndrome are chronic fatigue, breathlessness, depression or anxiety, pain, cough and alopecia, and many of them are still present 6 months after hospital discharge from the acute disease, depending on the gravity of the illness. It is important for patients to maintain medical follow-up to access severity of the symptoms and choose whether further investigation is necessary. There are some treatments available to some minimize the long-lasting burden of the syndrome, and the physician should access the need for treatment with the patient. As a new disease, there is a lot of new evidence being produced rapidly, but no up-to-date protocol has already been published. Even with the vaccinations campaigns, the burden of the pandemic is yet out of sight, as it still killing thousands daily, and those who have recovered from the acute COVID-19 illness can present chronic symptoms. Therefore, we recommend health professionals to continuously up-to-date themselves, as new information is added to make better clinical decisions.
References
Ahmed H, Patel K, Greenwood D, Halpin S, Lewthwaite P, Salawu A, et al. (2020). Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med [Internet]. https://doi.org/10.2340/16501977-2694.
Alimohamadi Y, Sepandi M, Taghdir M & Hosamirudsari H. (2020). Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. J Prev Med Hyg [Internet]. 61(3):E304–12. https://doi.org/doi: 10.15167/2421-4248/jpmh2020.61.3.1530.
Arnold D. T, Hamilton F. W, Milne A, Morley A. J, Viner J, Attwood M, et al. (2021). Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax [Internet].76(4):399–401. https://doi.org/10.1136/thoraxjnl-2020-216086.
Barker-Davies R. M, O’Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, et al. (2020). The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med [Internet]. 54(16):949–59. https://doi.org/10.1136/bjsports-2020-102596.
Bowles K. H, McDonald M, Barrón Y, Kennedy E, O’Connor M, Mikkelsen M. (2021). Surviving COVID-19 After Hospital Discharge: Symptom, Functional, and Adverse Outcomes of Home Health Recipients. Ann Intern Med [Internet]. 174(3):316–25. https://doi.org/10.7326/M20-5206.
Carfì A, Bernabei R & Landi F. (2020). Persistent Symptoms in Patients After Acute COVID-19. JAMA [Internet]. 324(6):603. https://doi.org/10.1001/jama.2020.12603.
Carod Artal FJ. (2021). Síndrome post-COVID-19: epidemiología, criterios diagnósticos y mecanismos patogénicos implicados. Rev Neurol [Internet]. 72(11):384. https://doi.org/10.33588/rn.7211.2021230.CDC. (2021). Post-COVID Conditions.
Damm M, Pikart LK, Reimann H, Burkert S, Göktas Ö, Haxel B, et al. (2014). Olfactory training is helpful in postinfectious olfactory loss: A randomized, controlled, multicenter study. Laryngoscope [Internet]. 124(4):826–31. https://doi.org/10.1002/lary.24340 Available from: https://onlinelibrary.wiley.com/doi/10.1002/lary.24340
Dicpinigaitis, P. V., & Canning, B. J. (2020). Is There (Will There Be) a Post-COVID-19 Chronic Cough?. Lung, 198(6), 863–865. https://doi.org/10.1007/s00408-020-00406-6
Durmus E & Guneysu F. (2020). Evaluation of re-hospitalized COVID-19 patients in a hospital. Rev Assoc Med Bras [Internet]. 66(12):1690–5. https://doi.org/10.1590/1806-9282.66.12.1690.
Dyspnea. Mechanisms, assessment, and management: a consensus statement. (1999). American Thoracic Society. Am J Respir Crit Care Med. 59(1):321-40. 10.1164/ajrccm.159.1.ats898.
Goërtz Y. M. J, Van Herck M, Delbressine J. M, Vaes A. W, Meys R, Machado F. V. C. et al. (2020). Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res [Internet]. 6(4):00542–2020. https://doi.org/10.1183/23120541.00542-2020.
Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. (2020). Management of post-acute covid-19 in primary care. BMJ [Internet]. m3026. https://doi.org/10.1136/bmj.m3026.
Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., Liu, L., Shan, H., Lei, C. L., Hui, D., Du, B., Li, L. J., Zeng, G., Yuen, K. Y., Chen, R. C., Tang, C. L., Wang, T., Chen, P. Y., Xiang, J., Li, S. Y. China Medical Treatment Expert Group for Covid-19 (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. The New England journal of medicine, 382(18), 1708–1720. https://doi.org/10.1056/NEJMoa2002032.
Hadid T, Kafri Z & Al-Katib A. (2021). Coagulation and anticoagulation in COVID-19. Blood Rev [Internet]. 47:100761. https://doi.org/10.1016/j.blre.2020.100761.
Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. (2021). Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation. J Med Virol [Internet]. 93(2):1013–22. https://doi.org/10.1002/jmv.26368.
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet [Internet]. 397(10270):220–32. https://doi.org/10.1016/S0140-6736(20)32656-8. https://linkinghub.elsevier.com/retrieve/pii/S0140673620326568
Liu K, Zhang W, Yang Y, Zhang J, Li Y & Chen Y. (2020). Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract [Internet]. 39:101166. https://doi.org/10.1016/j.ctcp.2020.101166.
Meini S, Suardi LR, Busoni M, Roberts AT & Fortini A. (2020). Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: sex differences and recovery time in real-life. Eur Arch Oto-Rhino-Laryngology [Internet]. 277(12):3519–23. https://doi.org/10.1007/s00405-020-06102-8.
Mikkelsen AME & Abramoff B. (2021). COVID-19 : Evaluation and management of adults following acute viral illness. Up to Date [Internet]. 2019:1–34. https://www.uptodate.com/contents/covid-19-evaluation-and-management-of-adults-following-acute-viral-illness?search=covid 19 respiratory& source= search_result&selectedTitle=1~150&usage_type=default&display_rank=1
National Institute for Health and Care Excellence. (2020). Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (clinical guideline CG144) [Internet].
Nalbandian A, Sehgal K, Gupta A, Madhavan M V., McGroder C, Stevens JS, et al. (2021). Post-acute COVID-19 syndrome. Nat Med [Internet]. 22;27(4):601–15. https://doi.org/10.1038/s41591-021-01283-z.
O’Connor FG & Franzos A. (2021). COVID-19: Return to play or strenuous activity following infection [Internet]. Up to Date.
O’Driscoll BR, Howard LS, Earis J, Mak V. (2017). BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax [Internet]. 72(Suppl 1):ii1–90. https://doi.org/10.1136/thoraxjnl-2016-209729.
Oliviero A., de Castro F., Coperchini F., Chiovato L., Rotondi M. (2020). COVID-19 pulmonary and olfactory dysfunctions: is the chemokine CXCL10 the common denominator? Neuroscientist. 1–8. doi: 10.1177/1073858420939033.
Ortelli, P., Ferrazzoli, D., Sebastianelli, L., Engl, M., Romanello, R., Nardone, R., Bonini, I., Koch, G., Saltuari, L., Quartarone, A., Oliviero, A., Kofler, M., & Versace, V. (2021). Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom. Journal of the neurological sciences, 420, 117271. https://doi.org/10.1016/j.jns.2020.117271.
Perico, L., Benigni, A., Casiraghi, F., Ng, L., Renia, L., & Remuzzi, G. (2021). Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nature reviews. Nephrology, 17(1), 46–64. https://doi.org/10.1038/s41581-020-00357-4
Piraccini BM & Alessandrini A. (2014). Androgenetic alopecia. G Ital Dermatol Venereol [Internet]. 149(1):15–24.
Rawal G, Yadav S & Kumar R. (2017). Post-intensive care syndrome: An overview. J Transl Intern Med [Internet]. 5(2):90–2. https://doi.org/10.1515/jtim-2016-0016.
Rodríguez-Larrad A, Mañas A, Labayen I, González-Gross M, Espin A, Aznar S, et al. (2021). Impact of COVID-19 Confinement on Physical Activity and Sedentary Behaviour in Spanish University Students: Role of Gender. Int J Environ Res Public Health [Internet].;18(2):369. https://doi.org/10.3390/ijerph18020369.
Scangas GA & Bleier BS. (2017). Anosmia: Differential Diagnosis, Evaluation, and Management. Am J Rhinol Allergy [Internet]. 31(1):e3–7. https://doi.org/10.2500/ajra.2017.31.4403.
Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. (2021). Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J [Internet]. 57(4):2003481. https://doi.org/10.1183/13993003.03481-2020.
Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E, et al. (2020). COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Thromb Haemost [Internet]. 120(06):998–1000. https://doi.org/10.1055/s-0040-1710018.
Tang N, Li D, Wang X & Sun Z. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost [Internet].18(4):844–7. https://doi.org/10.1111/jth.14768.
Teixeira T. A, Bernardes F. S, Oliveira Y. C, Hsieh M. K, Esteves S. C, Duarte Neto A. N, et al. (2021). SARS-CoV-2 and Multi-Organ damage – What men’s health specialists should know about the COVID-19 pathophysiology. Int braz j urol [Internet].47(3):637–46. https://doi.org/10.1590/S1677-5538.IBJU.2020.0872.
Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., Clark, C., & Iba, T. (2020). ISTH interim guidance on recognition and management of coagulopathy in COVID-19. Journal of thrombosis and haemostasis : JTH, 18(5), 1023–1026. https://doi.org/10.1111/jth.14810
Udelson J. E, Rowin E. J & Maron B. J. (2021). Return to Play for Athletes After COVID-19 Infection. JAMA Cardiol [Internet]. https://doi.org/10.1001/jamacardio.2021.2079.
Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. (2021). Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 27(1):89–95. 10.1016/j.cmi.2020.09.023.
Wade D., Hardy R. & Howell DMM. (2013). Identifying clinical and acute psychological risk factors for PTSD after critical care: a systematic review. EmbaseMinerva Anestesiol. 2013;79(8):944–63.
Wambier C. G, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard Á, et al. (2020). Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign.” J Am Acad Dermatol [Internet]. 83(2):680–2.https://doi.org/10.1016/j.jaad.2020.05.079.
Wasserman D, Guzman-Sanchez DA, Scott K & McMichael A. (2007). Alopecia areata. Int J Dermatol [Internet]. 46(2):121–31. https://doi.org/10.1111/j.1365-4632.2007.03193.x Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1365-4632.2007.03193.x
Wootton DG, Dickinson L, Pertinez H, Court J, Eneje O, Keogan L, et al. (2017). A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days. Eur Respir J [Internet]. 49(6):1602170. https://doi.org/10.1183/13993003.02170-2016.
Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature [Internet]. 579(7798):270–3. https://doi.org/10.1038/s41586-020-2012-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Mariana Dias de Resende; Gabriel Dias de Resende; Lucas Nunes Riquieri; Ana Flávia Arantes dos Santos; Alexandre Cesar Alves de Castro; Mariana da Costa Rocha
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
